| SLE Patient No./Age, yr |
Thoracic Diagnosis |
FEV1, % Predicted |
FVC, % Predicted |
TLC, % Predicted |
DLCO, % Predicted |
DLCO Adjusted for Volume Averaging, % Predicted |
Prednisone Dosage per Day, mg |
Major Indication for HSCT |
Prior Mechanical Ventilation/ Supplemental Oxygen Use |
|
| 1/24 |
MVR |
52 |
60 |
67 |
49 |
86 |
40 |
ARF, HTN |
No/yes |
| 2/25 |
AAH/ALP BAL/by biopsy |
78 |
74 |
107 |
42 |
88 |
30 |
AAH |
Yes/yes |
| 3/26 |
SLS |
31 |
50 |
67 |
Unable to complete |
Unable to complete |
30 |
Hypoxia, musculoskeletal pain |
No/yes |
| 4/17 |
Pleurisy |
75 |
77 |
Not done |
93 |
60 |
40 |
Cerebritis, CRF |
No/yes |
| 5/39 |
ALP by biopsy |
75 |
76 |
76 |
41 |
62 |
20 |
Hypoxia, MS pain |
No/yes |
| 6/16 |
Pleurisy |
37 |
42 |
54 |
42 |
80 |
20 |
Cerebritis, glomerulonephritis |
No/no |
| 7/51 |
None |
80 |
81 |
68 |
81 |
116 |
18 |
MS pain |
No/no |
| 8/20 |
None |
51 |
52 |
69 |
63 |
94 |
18 |
Mucocutaneous vasculitis |
No/no |
| 9/28 |
None |
79 |
75 |
89 |
61 |
94 |
28 |
Glomerulonephritis, musculoskeletal pain |
No/no |
| 10/16 |
AAH by BAL |
79 |
86 |
80 |
42 |
76 |
10 |
AAH, cerebritis |
Yes/no |
| 11/27 |
Thoracic myelitis |
36 |
31 |
Not done |
23 |
55 |
20 |
Myelitis |
Yes/no |
| 12/50 |
SLS |
46 |
50 |
64 |
54 |
141 |
20 |
Hypoxia |
No/yes |
| 13/18 |
None |
62 |
67 |
94 |
67 |
62 |
30 |
Cerebritis |
No/no |
| 14/28 |
None |
159 |
154 |
170 |
127 |
114 |
20 |
Cerebritis, musculoskeletal pain |
No/no |
| 15/22 |
None |
77 |
72 |
71 |
83 |
110 |
30 |
Cerebritis, thrombocytopenia |
No/no |
| 16/38 |
Pulmonary vasculitis |
64 |
61 |
59 |
26 |
65 |
20 |
Cutaneous vasculitis |
No/yes |
| 17/20 |
History of PE, pleurisy |
40 |
36 |
44 |
41 |
143 |
20 |
Cerebritis, musculoskeletal pain |
No/yes |
| 18/45 |
Pleurisy |
62 |
48 |
67 |
54 |
94 |
20 |
Cerebritis, neuropathy |
No/no |
| 19/32 |
None |
72 |
69 |
68 |
57 |
80 |
30 |
AIHA, cerebritis |
No/no |
| 20/22 |
Pleurisy |
41 |
38 |
36 |
34 |
107 |
40 |
Cerebritis, musculoskeletal pain |
No/no |
| 21/29 |
None |
64 |
66 |
73 |
45 |
86 |
30 |
Cerebritis |
No/no |
| 22/22 |
Pleurisy, severe MVR |
85 |
79 |
85 |
44 |
57 |
20 |
Myocarditis, musculoskeletal pain |
No/no |
| 23/48 |
ALP |
48 |
56 |
99 |
Unable to complete |
Unable to complete |
None at time of testing |
Cerebritis, musculoskeletal pain |
No/no |
| 24/21 |
Pulmonary hypertension |
68 |
72 |
74 |
48 |
70 |
12 |
Calciphylaxis |
No/no |
| 25/52 |
None |
95 |
97 |
86 |
72 |
91 |
25 |
Cerebritis |
No/no |
| 26/34 |
None |
59 |
60 |
70 |
40 |
66 |
30 |
Cerebritis neuropathy |
No/no |
| 27/37 |
APLS, history of PE |
91 |
88 |
95 |
78 |
91 |
20 |
CVA, APLS |
No/no |
| 28/36 |
None |
77 |
75 |
65 |
39 |
47 |
7.5 |
Cerebritis, MS pain |
No/no |
| 29/40 |
None |
95 |
89 |
95 |
58 |
70 |
12 |
Cerebritis, MS pain |
No/no |
| 30/24 |
Thoracic myositis |
56 |
53 |
55 |
50 |
98 |
12 |
Myositis, muscuoskeletal pain |
No/no |
| 31/36 |
Pleurisy |
52 |
55 |
66 |
39 |
70 |
30 |
Cutaneous vasculitis, calcinosis, cerebritis |
No/no |
| 32/27 |
AAH |
66 |
66 |
78 |
42 |
73 |
12 |
AAH and nephritis |
Yes/yes |
| 33/32 |
History of PE |
76 |
75 |
77 |
54 |
74 |
5 |
Nephritis, musculoskeletal pain |
No/no |
| 34/27 |
None |
86 |
81 |
79 |
45 |
70 |
20 |
Cutaneous vasculitis |
No/no |
|